The Clorox Company (NYSE:CLX) has received a consensus “Reduce” rating from sixteen analysts, with an average 12-month price target of $117.93. This recommendation comes after mixed Q2 results, a year-over-year organic sales decline, and ongoing margin pressure, leading to multiple price target cuts. Despite these challenges, insider buying and a quarterly dividend offer some support for income investors.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The Clorox Company (NYSE:CLX) Receives Average Rating of "Reduce" from Analysts
The Clorox Company (NYSE:CLX) has received a consensus “Reduce” rating from sixteen analysts, with an average 12-month price target of $117.93. This recommendation comes after mixed Q2 results, a year-over-year organic sales decline, and ongoing margin pressure, leading to multiple price target cuts. Despite these challenges, insider buying and a quarterly dividend offer some support for income investors.